BerGenBio
Leader in understanding the central role of AXL kinase in promoting cancer spread, immune evasion and drug resistance.
Enterprise value
($10m)
Share price
NOK1.40 BGBIO.OL
Company register number
992219688
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | NOK250m | Post IPO Equity |
| Total Funding | 000k | ||
Investinor(exited)
Sarsia Seed Management(exited)
Birk Venture(exited)
Meteva AS(exited)
Sarsia(exited)
Televenture(exited)
| NOK | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 345 % | (93 %) | 29 % | (50 %) | (9 %) | 140 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (9700 %) | (2229 %) | (42641 %) | (39793 %) | (77357 %) | (53559 %) | (15817 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (9600 %) | (2239 %) | (42767 %) | (39970 %) | (77666 %) | (53786 %) | (16425 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 238 % | 3626 % | 1647 % | 2144 % | 30448 % | 10341 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.